1. Up front

   Up front 19 May 2016 Pages: 1331 - 1332

2. SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?

   • Naveed Sattar
   • James McLaren
   • John J. McMurray

   Review Open access 25 April 2016 Pages: 1333 - 1339

   

3. In vivo imaging of beta cells with radiotracers: state of the art, prospects and recommendations for development and use

   • Olof Eriksson
   • Maren Laughlin
   • Martin Gotthardt

   Review 19 April 2016 Pages: 1340 - 1349

   

4. Islet-intrinsic effects of CFTR mutation

   • Fiona N. Manderson Koivula
   • Neville H. McClenaghan
   • Catriona Kelly

   Review Open access 31 March 2016 Pages: 1350 - 1355

   

5. Serotonin competence of mouse beta cells during pregnancy

   • Lotte Goyvaerts
   • Anica Schraenen
   • Frans Schuit

   Review 07 April 2016 Pages: 1356 - 1363

   

6. An overview of glucagon research

   • Isabel Valverde

   Commentary 26 April 2016 Pages: 1364 - 1366

   

7. Glucagon action in the brain

   • Mona A. Abraham
   • Tony K. T. Lam

   Mini-review 26 April 2016 Pages: 1367 - 1371

   

8. Glucagon is the key factor in the development of diabetes

   • Young H. Lee
   • May-Yun Wang
   • Roger H. Unger

   Mini-review 26 April 2016 Pages: 1372 - 1375

9. Glucagon: acute actions on hepatic metabolism

   • Russell A. Miller
   • Morris J. Birnbaum

   Mini-Review 26 April 2016 Pages: 1376 - 1381

   

10. Gestational diabetes: what’s up?

    • Kerstin E. Berntorp

    Commentary 12 May 2016 Pages: 1382 - 1384

    

11. Risk factors for gestational diabetes: is prevention possible?

    • Cuilin Zhang
    • Shristi Rawal
    • Yap Seng Chong

    Mini-Review 10 May 2016 Pages: 1385 - 1390

12. Is it worth treating gestational diabetes: if so, when and how?

    • Marja Vääräsmäki

    Mini-Review 11 May 2016 Pages: 1391 - 1395

13. Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark

    • Peter Damm
    • Azadeh Houshmand-Oeregaard
    • Tine D. Clausen

    MINI-Review 12 May 2016 Pages: 1396 - 1399

14. The power of numbers

    • Marco Dauriz
    • James B. Meigs

    Commentary 26 April 2016 Pages: 1400 - 1402

15. Quantification of the type 2 diabetes risk in women with gestational diabetes: a systematic review and meta-analysis of 95,750 women

    • Girish Rayanagoudar
    • Amal A. Hashi
    • Shakila Thangaratinam

    Meta-Analysis Open access 13 April 2016 Pages: 1403 - 1411

    

16. Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

    • Lennart Tonneijck
    • Mark M. Smits
    • Daniël H. van Raalte

    Article Open access 01 April 2016 Pages: 1412 - 1421

    

17. Higher body fat percentage is associated with enhanced temperature perception in NAFLD: results from the randomised Wessex Evaluation of fatty Liver and Cardiovascular markers in NAFLD with OMacor thErapy trial (WELCOME) trial

    • Geraldine F. Clough
    • Keith G. McCormick
    • Christopher D. Byrne

    Article 22 April 2016 Pages: 1422 - 1429

    

18. Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk

    • Natascia Vedovato
    • Edward Cliff
    • Frances M. Ashcroft

    Article Open access 27 April 2016 Pages: 1430 - 1436

    

19. Burden of diabetes in Australia: life expectancy and disability-free life expectancy in adults with diabetes

    • Lili Huo
    • Jonathan E. Shaw
    • Dianna J. Magliano

    Article 14 April 2016 Pages: 1437 - 1445

    

20. Evaluation of type 2 diabetes genetic risk variants in Chinese adults: findings from 93,000 individuals from the China Kadoorie Biobank

    • Wei Gan
    • Robin G. Walters
    • on behalf of the China Kadoorie Biobank Collaborative Group

    Article Open access 06 April 2016 Pages: 1446 - 1457

    

21. Impaired pancreatic beta cell compensatory function is the main cause of type 2 diabetes in individuals with high genetic risk: a 9 year prospective cohort study in the Chinese population

    • Jing Yan
    • Danfeng Peng
    • Weiping Jia

    Article 23 March 2016 Pages: 1458 - 1462

    

22. Differential regulation of serum microRNA expression by HNF1β and HNF1α transcription factors

    • Wojciech Fendler
    • Joanna Madzio
    • Wojciech Mlynarski

    Article Open access 08 April 2016 Pages: 1463 - 1473

    

23. The zinc finger transcription factor PW1/PEG3 restrains murine beta cell cycling

    • Mozhdeh Sojoodi
    • Leslie Stradiot
    • Paola Bonfanti

    Article Open access 29 April 2016 Pages: 1474 - 1479

    

24. Autophagy is a major regulator of beta cell insulin homeostasis

    • Yael Riahi
    • Jakob D. Wikstrom
    • Gil Leibowitz

    Article 30 January 2016 Pages: 1480 - 1491

    

25. Hypoxia reduces ER-to-Golgi protein trafficking and increases cell death by inhibiting the adaptive unfolded protein response in mouse beta cells

    • Mohammed Bensellam
    • Emma L. Maxwell
    • D. Ross Laybutt

    Article 04 April 2016 Pages: 1492 - 1502

    

26. Inactivation of class II PI3K-C2α induces leptin resistance, age-dependent insulin resistance and obesity in male mice

    • Samira Alliouachene
    • Benoit Bilanges
    • Bart Vanhaesebroeck

    Article Open access 30 April 2016 Pages: 1503 - 1512

    

27. Neuronal human BACE1 knockin induces systemic diabetes in mice

    • Kaja Plucińska
    • Ruta Dekeryte
    • Bettina Platt

    Article Open access 02 May 2016 Pages: 1513 - 1523

    

28. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice

    • Caifeng Yan
    • Jinfeng Chen
    • Xiubin Liang

    Article 22 March 2016 Pages: 1524 - 1532

    

29. Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin

    • Atsushi Iida
    • Yusuke Seino
    • Yoshitaka Hayashi

    Article Open access 06 April 2016 Pages: 1533 - 1541

    

30. Prospective study on microangiopathy in type 2 diabetic foot ulcer

    • Fabio Fiordaliso
    • Giacomo Clerici
    • Ezio Faglia

    Article 28 April 2016 Pages: 1542 - 1548

    

31. Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria

    • Bernt Johan von Scholten
    • Henrik Reinhard
    • Peter Rossing

    Article 31 March 2016 Pages: 1549 - 1557

    

32. C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21

    • Hao Wu
    • Lili Kong
    • Lu Cai

    Article 26 April 2016 Pages: 1558 - 1568

    

33. The intriguing relationship between epilepsy and type 1 diabetes mellitus

    • Josemir W. Sander
    • Jan Novy
    • Mark R. Keezer

    Letter 18 May 2016 Pages: 1569 - 1570

34. The intriguing relationship between epilepsy and type 1 diabetes mellitus. Reply to Sander JW, Novy J, Keezer MR [letter]

    • I-Ching Chou
    • Chia-Hung Kao

    Letter 18 May 2016 Pages: 1571 - 1572

35. Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?

    • Naveed Sattar
    • James McLaren
    • John J. McMurray

    Erratum 12 May 2016 Pages: 1573 - 1574

    

36. Erratum to: Autophagy is a major regulator of beta cell insulin homeostasis

    • Yael Riahi
    • Jakob D. Wikstrom
    • Gil Leibowitz

    Erratum 17 May 2016 Pages: 1575 - 1576